Tag Archives: psilocybin research

Psilocybin and Cocaine Use Research: What the Latest Clinical Trial Signal Means for Canadians

A newly reported randomized clinical trial has renewed interest in psilocybin-assisted research for cocaine use. Here is what Canadians should understand about the findings, limitations, legal status, and safety considerations.

Psilocybin and Depression in Canada: Why the Therapeutic Experience Still Matters

Research into psilocybin and depression is moving beyond a simple question of whether a psychedelic experience is necessary. This Canadian guide explains what scientists are investigating, why preparation and support remain important, and what legal and safety considerations matter.

Psilocybin and Cocaine Use Research in Canada: What New Findings Do—and Do Not—Show

Emerging research is examining whether psilocybin-assisted interventions could help reduce cocaine use. Here is what Canadian readers should understand about the evidence, limitations, safety, and legal context.

Microdosing Mushrooms in Canada: An Evidence-Aware Guide to Safer Decisions

Microdosing mushrooms is widely discussed, but online claims often move faster than the evidence. This practical Canadian guide explains what microdosing means, what researchers know, common risks, legal considerations, and how to make more informed decisions.

Psilocybin News in Canada: How to Separate Science from Hype

Psilocybin coverage is growing quickly in Canada, but headlines do not always reflect the strength of the science. This educational guide explains how to evaluate claims, understand legal context, compare cultivar information, and make safer decisions.

Psychedelic Therapy Access in Canada: Why Overlooked Communities Need a Bigger Conversation

Interest in psychedelic therapy is expanding beyond veteran care. Learn why inclusive research, legal awareness, screening, and responsible education matter for Canadians exploring psilocybin and psychedelic medicine.

Psilocybin Policy in Canada 2026: What the Latest News Means for Magic Mushroom Buyers

Canada’s psilocybin landscape is shifting again in 2026. From Ottawa dispensary charges to a growing natural-psilocybin industry, here’s what the latest policy signals actually mean for magic mushroom buyers — and how to shop smartly in an evolving market.

Psilocybin and Aggression: What a 2026 Fish Study Reveals About Magic Mushrooms and Emotional Regulation

A 2026 Science Daily report found that psilocybin reduced aggressive behavior in fish. While animal models are not human trials, the finding adds to a growing body of research on how psilocybin interacts with emotional regulation. Here’s what Canadian magic mushroom users should take away — and what they shouldn’t.

Psilocybin Microdosing in Canada: What the 2026 Research Says About Dose, Sex Differences, and Safety

A wave of 2026 studies is reshaping how researchers think about psilocybin microdosing — from sex-based differences in response to how psilocybin leaves a distinct fingerprint on the brain. Here is what the science actually says, and how Canadian microdosers can apply it to dose, product choice, and safety.